1stOncology™: Cancer Intelligence Service – Page 8246 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Protara Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

On September 7, 2021 Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, reported that management will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually on September 13-15, 2021 (Press release, Protara Therapeutics, SEP 7, 2021, View Source [SID1234587362]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

The prerecorded presentation will become available on Monday, September 13, 2021 at 7:00am ET and can be accessed by visiting the Events and Presentations section of the Company’s website: View Source The webcast will be archived on the Company’s website for 90 days following the presentation.

Neoleukin Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference

On September 7, 2021 Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, reported that Jonathan Drachman, M.D., Chief Executive Officer, will present a corporate overview during the H.C. Wainwright 23RD Annual Global Life Sciences Conference taking place September 13-15, 2021 (Press release, Neoleukin Therapeutics, SEP 7, 2021, View Source [SID1234587361]).

A pre-recorded presentation will be available for on-demand access beginning at 7:00 am ET on Monday, September 13, 2021 from the investors section of the Neoleukin website at View Source An archived replay will also be available on the company website for at least 30 days following the event.

Merus to Participate in Upcoming Investor Conferences

On September 7, 2021 Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics and Triclonics), reported that Bill Lundberg, M.D., Chief Executive Officer of Merus, will participate in the following investor conferences (Press release, Merus, SEP 7, 2021, View Source [SID1234587360]):

Citi’s 16th Annual BioPharma Virtual Conference (Panel discussion): Thursday, Sept. 9, 2021 at 1:25-2:25 p.m. ET
H.C. Wainwright 23rd Annual Global Investment Conference (Presentation): Pre-recorded and available starting September 13 at 7:00 a.m. ET
2021 Cantor Virtual Global Healthcare (Presentation): Monday, September 27, 2021 at 2:40-3:10 p.m. ET
The webcast of the presentations will be available on the Investors page of the Company’s website. Archived presentations will also be available there for a limited time after the event.

Arbutus to Participate in Upcoming Investor Conferences

On September 7, 2021 Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), reported that the Company will participate in the following upcoming virtual investor conferences (Press release, Arbutus Biopharma, SEP 7, 2021, View Source [SID1234587359]):

H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021)

Fireside Chat: available starting at 7:00 am ET on Monday, September 13, 2021
Presenters: William Collier, President and Chief Executive Officer; Dr. Michael Sofia, Chief Scientific Officer; Dr. Gaston Picchio, Chief Development Officer; and David Hastings, Chief Financial Officer
Webcast Link
Cantor Global Healthcare Conference (September 27-30, 2021)

Formal Presentation: Thursday, September 30, 2021 at 8:40 am ET
Presenter: William Collier, President and Chief Executive Officer
Webcast Link
The webcast links can also be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com. An archived replay of the webcast will be available on the Company’s website after the conference.

Checkmate Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

On September 7, 2021 Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) ("Checkmate"), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, reported that Barry Labinger, CEO, will present at the H.C. Wainwright 23rd Annual Global Investment Conference (Press release, Checkmate Pharmaceuticals, SEP 7, 2021, View Source [SID1234587358]). The pre-recorded webcast will be available on demand, starting on Monday, September 13, 2021 at 7:00am ET. Checkmate will also host 1×1 investor meetings during the conference.